ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Surescripts Unveils Innovative Touchless Prior Authorization Technology

Providing a holistic solution that alleviates delays in patient access to treatments while improving efficiency for clinicians, care managers

Surescripts®, the nation's leading health information network, unveils the first-of-its-kind Touchless Prior Authorization technology, transforming prior authorizations to help alleviate one of healthcare’s most pressing challenges for care providers and patients.

Surescripts Touchless Prior Authorization helps automate existing manual workflows, significantly reducing the time-consuming administrative tasks often required for medication prior authorizations, returning time to prescribers, pharmacists and care managers while quickly getting patients started on the best treatment path.

“With a strong foundation of nationwide interoperability and a focus on innovation born out of cross-industry collaboration, Surescripts is thrilled to bring Touchless Prior Authorization to care providers and payers nationwide,” said Frank Harvey, Chief Executive Officer for Surescripts. “This technology can meaningfully transform the existing burdensome prior authorization process, helping patients get started on high-quality, affordable, evidence-based treatment that is covered by their health plan -- without delay.”

In a 2024 pilot, conducted in collaboration with leading health systems such as Fairview Health Services, the appeals and denials caused by a lack of clinical information were reduced by 88% and 68% respectively, and many approvals were completed in less than 30 seconds with this innovative technology.

“Prior authorizations have long been a frustrating and time-consuming hurdle for both providers and patients,” said Mel Nelson, Vice President of Specialty Pharmacy Consulting for Fairview. “It’s essential to find ways to simplify the process so patients get the medications they need faster, and clinicians can focus on care instead of paperwork. Technology continues to be a powerful tool in making healthcare more efficient and patient centered."

“When we’re sick, we shouldn’t have to think twice about the steps that happen between receiving a diagnosis from a clinician, being prescribed a treatment and taking the first dose of a medication,” said Tara Dragert, Chief Product Officer for Surescripts. “That was the purpose driving the innovative collaboration to develop Touchless Prior Authorization. This technology will ensure patients can quickly access safe, quality treatment they need and deserve, while significantly reducing the administrative burdens facing all sides of the patient care team.”

As of 2023, over one-third of medical plans had an entirely manual prior authorization process that depended on phone, mail, fax and email.

Another survey showed that 87% of physicians said that the prior authorization process can increase healthcare utilization as patients try other ineffective treatments or make additional office visits—and potentially seek more expensive care such as emergency room visits—when they encounter prior authorization barriers.

Learn more in this KLAS Research case study about how Surescripts Touchless Prior Authorization technology is making it easier for electronic health records vendors, pharmacy benefit managers, health systems and clinicians to get patients the care they deserve.

Surescripts @ ViVE 2025

Connect with Surescripts at ViVE in Nashville, February 16-19, at Booth #1245 to learn more about the results of the innovative collaboration that is transforming the prior authorization process.

Join Dr. Lynne Nowak, Chief Data & Analytics Officer for Surescripts, for Transforming Prior Authorization, on Monday, February 17, 10:45 – 11:05 a.m. CT at the InteropNow! Pavilion - Data Innovation Theater.

Dr. Nowak will present the results of a recent partnership to reimagine the prior authorization workflow for greater efficiency, a better experience for prescribers and faster speed to therapy for patients.

For Media: Dr. Nowak will also be available to answer questions at ViVE. Please contact Kate Giaquinto to schedule an interview.

About Surescripts

Our purpose is to serve the nation through simpler, trusted health intelligence sharing, in order to increase patient safety, lower costs and ensure quality care. At Surescripts, we align healthcare organizations across the nation and convene the Surescripts Network Alliance® to give healthcare professionals the trusted insights they need to serve patients. Together, we're bringing more intelligence to prescribing, informing treatment and care management with interoperability, and making it simpler to handle benefits and authorizations so patients get high-quality, affordable care sooner. Visit us at surescripts.com and follow us on LinkedIn.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.